Emergence of a novel recombinant of CV-A5 in HFMD epidemics in Xiangyang, China

Yuting Yu1, Zhiyu Luo1, Weiping Jin1

  • 1Wuhan Institute of Biological Products, Co. Ltd, Wuhan, 430207, People's Republic of China.

BMC Medical Genomics
|November 25, 2021
PubMed
Abstract

Insights

Enterovirus serotype CV-A5 emerged as a major cause of Hand, Foot, and Mouth Disease (HFMD) due to recombination with CV-A2. This finding highlights the need for a multivalent vaccine to control HFMD outbreaks.

Area of Science:

  • Virology
  • Epidemiology
  • Molecular Biology

Background:

  • Hand, Foot, and Mouth Disease (HFMD) is a contagious viral illness caused by various enteroviruses.
  • The global etiological landscape of HFMD has shifted significantly since the major outbreaks in 1997.

Purpose of the Study:

  • To investigate the genetic characteristics and evolutionary dynamics of enterovirus serotype 5 (CV-A5) strains.
  • To understand the role of CV-A5 in recent HFMD epidemics in Xiangyang.

Main Methods:

  • Collection and analysis of clinical HFMD specimens.
  • Genotyping using qRT-PCR, conventional PCR, and sequencing.
  • Whole-genome sequencing and phylogenetic analysis of CV-A5 strains.

Main Results:

  • CV-A5 was identified as one of the six predominant serotypes causing HFMD between October 2016 and December 2017.
  • Phylogenetic analysis confirmed CV-A5 strains belonged to the dominant Chinese genotype D.
  • Evidence of recombination between CV-A5 and CV-A2 was found in the 2A region.

Conclusions:

  • Recombination may explain the emergence of CV-A5 as a major HFMD pathogen.
  • A multivalent vaccine is crucial for controlling HFMD and preventing novel recombinant strains.